FORMER BOLAR CEO SHULMAN SENTENCED TO FIVE YEARS IN NAIL AND $1.25 MIL. FINE ON FIVE COUNTS OF FRAUD AND ONE COUNT OF FIXING GENERIC DYAZIDE PRICES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".